Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer : The status of cancer vaccine therapies in urologyTHOMPSON, R. Houston; ALLISON, James P; KWON, Eugene D et al.Urologic oncology. 2006, Vol 24, Num 5, pp 442-447, issn 1078-1439, 6 p.Article

Immunotherapy for urological malignanciesKREJCI, Kent G; MARKIEWICZ, Mary A; KWON, Eugene D et al.The Journal of urology. 2004, Vol 171, Num 2, pp 870-876, issn 0022-5347, 7 p., 1Article

Immunotherapy for prostate cancer : New therapies in prostate cancer: Controlling metastatic disease and preventing oncogenesisJEFFREY KARNES, R; WHELAN, Christopher M; KWON, Eugene D et al.Current pharmaceutical design. 2006, Vol 12, Num 7, pp 807-817, issn 1381-6128, 11 p.Article

External Validation of IMP3 Expression as an Independent Prognostic Marker for Metastatic Progression and Death for Patients With Clear Cell Renal Cell CarcinomaHOFFMANN, Nathan E; SHEININ, Yuri; LOHSE, Christine M et al.Cancer. 2008, Vol 112, Num 7, pp 1471-1479, issn 0008-543X, 9 p.Article

Predicting Disease Progression After Nephrectomy for Localized Renal Cell Carcinoma : The Utility of Prognostic Models and Molecular BiomarkersCRISPEN, Paul L; BOORJIAN, Stephen A; LOHSE, Christine M et al.Cancer. 2008, Vol 113, Num 3, pp 450-460, issn 0008-543X, 11 p.Article

B7-H3 ligand expression by prostate cancer : A novel marker of prognosis and potential target for therapyROTH, Timothy J; SHEININ, Yuri; CHEVILLE, John C et al.Cancer research (Baltimore). 2007, Vol 67, Num 16, pp 7893-7900, issn 0008-5472, 8 p.Article

Outcomes of gleason score 10 prostate carcinoma treated by radical prostatectomyINMAN, Brant A; DIMARCO, David S; SLEZAK, Jeffrey M et al.Urology (Ridgewood, NJ). 2006, Vol 68, Num 3, pp 604-608, issn 0090-4295, 5 p.Article

The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma. CommentaryKRAMBECK, Amy E; LEIBOVICH, Bradley C; LOHSE, Christine M et al.The Journal of urology. 2006, Vol 176, Num 5, pp 1990-1995, issn 0022-5347, 6 p.Article

Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?HOUSTON THOMPSON, R; LEIBOVICH, Bradley C; CHEVILLE, John C et al.The Journal of urology. 2005, Vol 173, Num 3, pp 918-921, issn 0022-5347, 4 p.Article

pT2 classification for renal cell carcinoma. Can its accuracy be improved?FRANK, Igor; BLUTE, Michael L; LEIBOVICH, Bradley C et al.The Journal of urology. 2005, Vol 173, Num 2, pp 380-384, issn 0022-5347, 5 p.Article

Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen : Prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate miceDAMU YANG; HOLT, Gregory E; VELDERS, Markwin P et al.Cancer research (Baltimore). 2001, Vol 61, Num 15, pp 5857-5860, issn 0008-5472Article

Operational Characteristics of ¹¹C-Choline Positron Emission Tomography/Computerized Tomography for Prostate Cancer with Biochemical Recurrence After Initial TreatmentMITCHELL, Christopher R; LOWE, Val J; RANGEL, Laureano J et al.The Journal of urology. 2013, Vol 189, Num 4, pp 1308-1313, issn 0022-5347, 6 p.Article

EVALUATION OF B7-H3 EXPRESSION AS A BIOMARKER OF BIOCHEMICAL RECURRENCE AFTER SALVAGE RADIATION THERAPY FOR RECURRENT PROSTATE CANCERPARKER, Alexander S; HECKMAN, Michael G; SHEININ, Yuri et al.International journal of radiation oncology, biology, physics. 2011, Vol 79, Num 5, pp 1343-1349, issn 0360-3016, 7 p.Article

Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndromeWADA, David A; WILCOX, Ryan A; HARRINGTON, Susan M et al.American journal of hematology. 2011, Vol 86, Num 3, pp 325-327, issn 0361-8609, 3 p.Article

T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma : Clinicopathologic Correlations and Association with SurvivalBOORJIAN, Stephen A; SHEININ, Yuri; CRISPEN, Paul L et al.Clinical cancer research (Print). 2008, Vol 14, Num 15, pp 4800-4808, issn 1078-0432, 9 p.Article

Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinomaLEIBOVICH, Bradley C; SHEININ, Yuri; LOHSE, Christine M et al.Journal of clinical oncology. 2007, Vol 25, Num 30, pp 4757-4764, issn 0732-183X, 8 p.Article

PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinomaTHOMPSON, R. Houston; HAIDONG DONG; LOHSE, Christine M et al.Clinical cancer research. 2007, Vol 13, Num 6, pp 1757-1761, issn 1078-0432, 5 p.Article

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-upTHOMPSON, R. Houston; KUNTZ, Susan M; BLUTE, Michael L et al.Cancer research (Baltimore). 2006, Vol 66, Num 7, pp 3381-3385, issn 0008-5472, 5 p.Article

Prostate cancer immunology : Biology, therapeutics, and challengesWEBSTER, W. Scott; SMALL, Eric J; RINI, Brian I et al.Journal of clinical oncology. 2005, Vol 23, Num 32, pp 8262-8269, issn 0732-183X, 8 p.Article

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: A stratification tool for prospective clinical trialsLEIBOVICH, Bradley C; BLUTE, Michael L; CHEVILLE, John C et al.Cancer. 2003, Vol 97, Num 7, pp 1663-1671, issn 0008-543X, 9 p.Article

Potential Role of Genetic Markers in the Management of Kidney CancerJUNKER, Kerstin; FICARRA, Vincenzo; KWON, Eugene D et al.European urology. 2013, Vol 63, Num 2, pp 333-340, issn 0302-2838, 8 p.Article

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disordersWILCOX, Ryan A; FELDMAN, Andrew L; WITZIG, Thomas E et al.Blood. 2009, Vol 114, Num 10, pp 2149-2158, issn 0006-4971, 10 p.Article

Positive Surgical Margins at Partial Nephrectomy : Predictors and Oncological OutcomesYOSSEPOWITCH, Ofer; THOMPSON, R. Houston; LEIBOVICH, Bradley C et al.The Journal of urology. 2008, Vol 179, Num 6, pp 2158-2163, issn 0022-5347, 6 p.Article

Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell CarcinomaCRISPEN, Paul L; SHEININ, Yuri; BLUTE, Michael L et al.Clinical cancer research (Print). 2008, Vol 14, Num 16, pp 5150-5157, issn 1078-0432, 8 p.Article

Early effects of pharmacological androgen deprivation in human prostate cancerMERCADER, Maria; SENGUPTA, Shomik; BODNERT, Barbara K et al.BJU international (Papier). 2007, Vol 99, Num 1, pp 60-67, issn 1464-4096, 8 p.Article